Accumulation of Triglyceride-Rich Lipoprotein in Subjects With Abdominal Obesity: The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 Study

• Published in: Arteriosclerosis, thrombosis, and vascular biology Vol. 21; no. 3; pp. 407 - 414
• Main Authors: Bard, J.M, Charles, M.A, Juhan-Vague, I, Vague, P, André, P, Safar, M, Fruchart, J.C, Eschwege, E
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Heart Association, Inc 01.03.2001; Hagerstown, MD Lippincott
• Subjects: Abdomen; Adult; Aged; Biguanides - therapeutic use; Biological and medical sciences; Biomarkers - blood; Cardiovascular Diseases - prevention & control; Endothelium, Vascular - drug effects; Endothelium, Vascular - pathology; Female; Fibrinolysis - drug effects; Humans; Hypoglycemic Agents - therapeutic use; Insulin - blood; Insulin Resistance; Lipoproteins - blood; Male; Medical sciences; Metabolic diseases; Metformin - therapeutic use; Middle Aged; Obesity; Obesity - blood; Obesity - prevention & control; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Statistics as Topic; Triglycerides - blood; Human; Obesity; Target tissue resistance; Biguanides; Pathogenesis; Nutrition disorder; Lipoprotein; Insulin; Nutritional status; Abdomen
• ISSN: 1079-5642; 1524-4636
• DOI: 10.1161/01.ATV.21.3.407

Abstract —The present study represents a new insight into the Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study population at inclusion. This population, selected basically on the basis of a high waist-to-hip ratio (≥0.95 for men and ≥0.80 for women), is supposed to represent a group of patients with insulin resistance. The present study was undergone to establish whether apolipoprotein C-III (apoC-III) and apolipoprotein E (apoE) associated with apo B (apoC-III LpB and apoE LpB, respectively), considered to be markers of remnant accumulation, play a role in the hypertriglyceridemia associated with insulin resistance and whether they are related to other biological abnormalities frequently observed in this syndrome. In this population, the concentration of the markers of remnant accumulation increases with triglyceride levels. Therefore, correlation studies were realized to assess the relative effect of insulin and the markers of remnant accumulation on triglyceride plasma level. As a first attempt, a simple correlation analysis revealed that insulin is positively related to the markers of remnant accumulation only in hypertriglyceridemic patients (triglycerides ≥1.7 mmol/L). To assess the independent contribution of these markers, insulin, and other parameters related to the plasma triglyceride concentration, a stepwise multiple regression analysis was run. Results revealed that insulin and the markers of remnant accumulation (specifically, apoE LpB) are independent contributors to the plasma triglyceride concentration. Markers of the endothelial damage, plasminogen activator inhibitor-1, tissue plasminogen activator, and von Willebrand factor, which are often increased in the case of insulin resistance, were tested for their correlation with the markers of remnant accumulation. Plasminogen activator inhibitor-1 is positively correlated with these markers only in hypertriglyceridemic male subjects. It is concluded that increased insulin levels found in insulin resistance syndrome are associated with an increased production of triglyceride-rich lipoproteins enriched in apoC-III and apoE. The accumulation of these remnants and/or their abnormal composition in apoC-III and apoE could be an explanation for the development of hypertriglyceridemia in this syndrome.